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Possible reactivation of hepatitis D with 
chronic δ antigenaemia by human 
immunodeficiency virus 
We describe a case of reactivation of infection with hepatitis D virus (δ) in an intravenous drug 
abuser who was a carrier of hepatitis B surface antigen (HBsAg). This condition was manifested 
by chronic & antigenaemia of at least two years’ standing and was probably induced by infection 
with human immunodeficiency virus. 
 
Seroconversion of antihuman immunodeficiency virus antibody  
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Temporal changes in results of detailed serological tests for hepatitis B and D viruses in 21 year 
old drug abuser. 
Case report 
 Detailed serological tests for hepatitis B and D viruses were carried out on a series of 
specimens from a21yearoldmaledrug abuser in whom acute hepatitis B had been diagnosed in 
February 1983. At that time HBsAg was detected by commercial radioimmunoassay and enzyme 
immunoassay kits (Abbott); hepatitis B e antigen (HBeAg) and antihepatitis B core IgM were 
detected by in house enzyme immunoassays.’ There was no jaundice and his liver enzyme 
activities were slightly raised. Jaundice of three weeks’ duration occurred six months later, 
however, in August 1983. 
 Antihepatitis D IgG was detected in October 1983 by enzyme immunoassay (Deltassay B, 
Noctech). Antihepatitis D IgM was also detected by an in house enzyme linked immunosorbent 
assay (ELISA) using hepatitis D antigen (HDAg) derived from serum, which indicated that his 
hepatitis in August had been caused by a superinfection with hepatitis D virus. Antihepatitis D 
IgG persisted throughout 1984. 
 Reactivation of infection with hepatitis D virus was first detected in July 1984, when 
transient HDAg appeared resulting in seroconversion to antihepatitis D IgM. Reactivation was 
again detected in January 1985, after which he showed increasing amounts of serum HDAg 
(detected by enzyme immunoassay Deltassay, Noctech) with loss of antihepatitis D IgG and 
fluctuating amounts of antihepatitis D IgM. 
 Tests for antibody to human immunodeficiency virus were carried out retrospectively. 
Enzyme immunoassay gave an equivocal result at first, but a Western blot analysis (using DuPont 
preprepared nitrocellulose strips) produced a positive result in his specimen of October 1983; all 
subsequent tests (Wellcome enzyme immunoassay) remained positive. The activities of his liver 
enzymes were persistently raised and variable throughout, and a liver biopsy in October 1984 
indicated the presence of chronic active hepatitis. In October 1986 he had lymphadenopathy but 
had not returned for follow up at the time of writing. 
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 The serological results strongly suggest that our patient acquired superinfection with 
hepatitis D virus and human immunodeficiency virus about six months after acute infection with 
hepatitis B virus. The unusual serological pattern and the rising concentration of HDAg in serum 
strongly suggest reactivation of replication of hepatitis D virus. Furthermore, his most recent 
specimens showed reversion from antihepatitis B e antibody to HBeAg, which indicates 
reactivation of hepatitis B virus as well. Unfortunately the patient has been lost to follow up and 
the importance of this reactivation of hepatitis D virus is therefore unknown. Although this is the 
first reported occurrence of reactivation of infection with hepatitis D virus by human 
immunodeficiency virus, the large numbers of drug abusers in Dublin who are infected with 
hepatitis D virus2 and the increase of such infections in proportion with infections with human 
immunodeficiency virus (A G Shattock el al, international symposium on AIDS, Paris 1986) 
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make it likely that other reactivations of infection with hepatitis D virus will occur in this 
susceptible population. 
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